AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $258,000 | -16.5% | 5,600 | 0.0% | 0.01% | -17.6% |
| Q2 2021 | $309,000 | +6.9% | 5,600 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $289,000 | +18.9% | 5,600 | 0.0% | 0.02% | +13.3% |
| Q4 2020 | $243,000 | -18.7% | 5,600 | 0.0% | 0.02% | -37.5% |
| Q2 2020 | $299,000 | +12.0% | 5,600 | 0.0% | 0.02% | +26.3% |
| Q4 2019 | $267,000 | -4.3% | 5,600 | 0.0% | 0.02% | -13.6% |
| Q2 2019 | $279,000 | -26.2% | 5,600 | 0.0% | 0.02% | -29.0% |
| Q1 2019 | $378,000 | +46.5% | 5,600 | 0.0% | 0.03% | +29.2% |
| Q4 2018 | $258,000 | -40.3% | 5,600 | 0.0% | 0.02% | -31.4% |
| Q3 2018 | $432,000 | -8.5% | 5,600 | 0.0% | 0.04% | -12.5% |
| Q2 2018 | $472,000 | +3.1% | 5,600 | 0.0% | 0.04% | -2.4% |
| Q1 2018 | $458,000 | +43.1% | 5,600 | 0.0% | 0.04% | +41.4% |
| Q4 2017 | $320,000 | – | 5,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |